Skip to main content
. Author manuscript; available in PMC: 2013 Aug 21.
Published in final edited form as: Medchemcomm. 2012 Aug 21;3(10):1275–1281. doi: 10.1039/C2MD20206A

Fig. 2.

Fig. 2

Cytotoxicity profiles of (A) cisTEX (2) and (B) oxaliTEX (3) with cisplatin sensitive A2780 and cisplatin resistant 2780CP. The complex was made up as a stock solution (for which the Pt concentration was confirmed by FAAS) and serially diluted before adding to cells, which were then incubated for 5 days at 37 °C in 5% CO2. Error bars represent the standard deviation.